Latest filing published 22 Sept 2015 for Evofem Biosciences, Inc., €1,175.
Insider track record
No signal scores available.
Christopher Kemmerer: trading record in brief
Christopher Kemmerer appears in our data through filings on Evofem Biosciences, Inc. shares, published by SEC (Form 4). We count 6 filings; the first trade dates from 12 June 2015 and the latest from 18 September 2015.
Sales make up the whole of the open-market record (2 sales, €22k). Besides market trades, the filings include 4 option exercises.
On 22 September 2015 came the latest disclosure, an option exercise for €1,175 in Evofem Biosciences, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Kemmerer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$1.34Common StockSEC:0001209191-15-071843:0
- 1,000 shares@ US$12.20Common StockSEC:0001209191-15-071843:1
- 1,000 shares@ US$1.34Common StockSEC:0001209191-15-066382:0
- 1,000 shares@ US$1.22Common StockSEC:0001209191-15-065009:0
- 1,000 shares@ US$12.88Common StockSEC:0001209191-15-065009:1
- 10,848 shares@ US$1.22Common StockSEC:0001209191-15-053913:0
6 of 6 declarations